105 lines
3.0 KiB
JavaScript
105 lines
3.0 KiB
JavaScript
manufacturer = {
|
|
"valueSetId": "vaccines-covid-19-auth-holders",
|
|
"valueSetDate": "2021-04-27",
|
|
"valueSetValues": {
|
|
"ORG-100001699": {
|
|
"display": "AstraZeneca AB",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100030215": {
|
|
"display": "Biontech Manufacturing GmbH",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100001417": {
|
|
"display": "Janssen-Cilag International",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100031184": {
|
|
"display": "Moderna Biotech Spain S.L.",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100006270": {
|
|
"display": "Curevac AG",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100013793": {
|
|
"display": "CanSino Biologics",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100020693": {
|
|
"display": "China Sinopharm International Corp. - Beijing location",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100010771": {
|
|
"display": "Sinopharm Weiqida Europe Pharmaceutical s.r.o. - Prague location",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100024420": {
|
|
"display": "Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. - Shenzhen location",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"ORG-100032020": {
|
|
"display": "Novavax CZ AS",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "https://spor.ema.europa.eu/v1/organisations",
|
|
"version": ""
|
|
},
|
|
"Gamaleya-Research-Institute": {
|
|
"display": "Gamaleya Research Institute",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "http://ec.europa.eu/temp/vaccinemanufacturer",
|
|
"version": "1.0"
|
|
},
|
|
"Vector-Institute": {
|
|
"display": "Vector Institute",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "http://ec.europa.eu/temp/vaccinemanufacturer",
|
|
"version": "1.0"
|
|
},
|
|
"Sinovac-Biotech": {
|
|
"display": "Sinovac Biotech",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "http://ec.europa.eu/temp/vaccinemanufacturer",
|
|
"version": "1.0"
|
|
},
|
|
"Bharat-Biotech": {
|
|
"display": "Bharat Biotech",
|
|
"lang": "en",
|
|
"active": true,
|
|
"system": "http://ec.europa.eu/temp/vaccinemanufacturer",
|
|
"version": "1.0"
|
|
}
|
|
}
|
|
}
|